- Abstract -

This article brings proof regarding the benefits of antiplatelet therapy which definitely exceed the risk of haemorrhagic complications in a certain category of patients’ with different clinical manifestations of cardiovascular conditions.

The association of certain risk factors (age over 60, smoking, the presence of Helicobacter Pylori) increases the rate of side effects, especially gastrointestinal ones, after the administration of antiplatelet medication.

Key words: platelet antiagregants; aspirin, clopidogrel; Helicobacter Pylori, gastrointestinal complications; major cardiovascular events